on 14 Jan 2025
Last Applicant/ Owned by
Ultragenyx Pharmaceutical Inc.
60 Leveroni CourtNovato CA 94949
US
Serial Number
2283851 filed on 25th Aug 2023
Trademark usage description
pharmaceutical preparations and substances for the treatment of metabolic and rare diseases and disorders; gene therapy products for the treatment of Read More12
12
12
2283851
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 22 on 14th Jan 2025 | Search Recorded |
Submitted for opposition 20 on 14th Jan 2025 | Examiner's First Report |
Submitted for opposition 223 on 14th Jan 2025 | Total Provisional Refusal |
Submitted for opposition 256 on 29th Jul 2024 | Notification of Possible Opposition Sent |
Submitted for opposition 257 on 28th Sept 2023 | Designation Notification - Madrid Protocol |
Submitted for opposition 31 on 28th Sept 2023 | Formalized |
Submitted for opposition 1 on 28th Sept 2023 | Created |
Submitted for opposition 228 on 25th Aug 2023 | International Registration |
Submitted for opposition 30 on 25th Aug 2023 | Filed |